Imunon, Inc. (IMNN)
NASDAQ: IMNN · IEX Real-Time Price · USD
1.310
-0.035 (-2.60%)
Apr 30, 2024, 3:56 PM EDT - Market closed

Imunon Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
33
Market Cap
12.31M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20230--
Dec 31, 2022500.00K--
Dec 31, 2021500.00K--
Dec 31, 2020500.00K--
Dec 31, 2019500.00K--
Dec 31, 2018500.00K--
Dec 31, 2017500.00K--
Dec 31, 2016500.00K--
Dec 31, 2015500.00K--
Dec 31, 2014500.00K--
Dec 31, 2013500.00K--
Dec 31, 20120--
Dec 31, 20112.00M--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20082.50M--
Dec 31, 20070--
Dec 31, 20060--
Dec 31, 20050--
Dec 31, 20042.51M--
Sep 30, 20030--
Sep 30, 20020--
Sep 30, 20010--
Sep 30, 20003.42K--
Sep 30, 19990--
Sep 30, 1998174.18K52.93K43.65%
Sep 30, 1997121.26K47.25K63.85%
Sep 30, 199674.01K-83.61K-53.05%
Sep 30, 1995157.62K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 751.10M
Centogene 55.72M
Zhongchao 17.23M
Novo Integrated Sciences 13.66M
RedHill Biopharma 6.53M
NEXGEL 4.09M
Elevai Labs 1.71M
Revenue Rankings